Full Text
Factors Predicting Restrictions on US Commercial Payer Coverage of Specialty Drugs

Abstract

Authors

DD Kim E Pope CL Wilkinson JS Graff PJ Neumann JD Chambers

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×